The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC
Yun Sun Lee(Yonsei University), Joon Seong Park(Yonsei University)
Cited by 12
Related Papers
Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction
|Frontiers in Pharmacology|2022|25
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer
|Cancer Biology & Therapy|2023|14
Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via activation of LOXL2
|Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics|2024|7